Target intelligence / Profile preview

Renal transporter

Molecular classification
Transporter, Organic anion transporter (OAT family), Organic cation transporter (OCT family), Organic anion transporting polypeptide (OATP family), Multidrug and toxin extrusion protein (MATE family), Multidrug resistance-associated protein (MRP family), Sodium-glucose cotransporter (SGLT family), Peptide transporter (PEPT1, PEPT2), Primary active transporter (e.g., P-glycoprotein/MDR1, ATP-binding cassette transporters)
01

Overview

Renal transporters comprise multiple families of membrane proteins—including organic anion transporters (OATs), organic cation transporters (OCTs), multidrug and toxin extrusion proteins (MATEs), multidrug resistance proteins (MRPs), and others—primarily localized in the renal proximal tubule epithelium. They facilitate the selective, often charge-dependent transport of a wide range of endogenous compounds and therapeutic drugs from blood into urine (secretion) or from urine back to the blood (reabsorption)[1][2][4][5][7][10]. These transporters not only play central roles in drug disposition and renal elimination but also influence systemic homeostasis, inter-organ communication, and pathophysiological states including kidney diseases and cancer. Their functional status and genetic variability can critically affect drug efficacy, safety, and the potential for drug–drug interactions[1][4][5][7][9][10]. Due to their importance in pharmacotherapy, several renal transporters are directly targeted by drugs to modulate kidney function or improve disease outcomes[7]. However, the term "Renal transporter" is generic; for precise clinical or research applications, individual transporter names (e.g., "Organic anion transporter 1" for OAT1) should be specified.

Other names
Renal drug transporterkidney transporterrenal tubular transporter
02

Mechanism of action

Drug elimination via transporter-mediated secretion into urine - Competition or inhibition at the transporter leading to drug–drug interactions and altered pharmacokinetics - Modulation of transporter activity to achieve therapeutic effects (e.g., SGLT2 inhibition for diabetes, URAT1 inhibition for gout)

03

Biological functions

Tubular secretion of drugs and toxinsTubular reabsorption of nutrients (e.g., glucose, amino acids)Elimination of endogenous and exogenous compounds (metabolites, uremic toxins)Maintenance of homeostasis, acid-base balanceRegulation of urate and small-molecule communication between organs
04

Disease associations

Nephrotoxicity and drug-induced renal injuryCancer (renal cell carcinoma, multi-drug resistance)Chronic kidney disease, uremic toxin accumulationMetabolic diseases (e.g., uric acid transport defects, inherited transporter disorders)Pharmacokinetic variability in drug response and toxicity
05

Safety considerations

Nephrotoxicity due to transporter-mediated accumulation of toxic drugs/metabolitesDrug–drug interactions at shared transporters leading to decreased efficacy or increased toxicityGenetic polymorphisms affecting transporter function and variable drug responseTransporter-mediated resistance mechanisms (in cancer or antimicrobial therapy)
06

Interacting drugs

Furosemide, probenecid (OAT1/3)

5 more in the full profile.

07

Biomarkers

Creatinine and uric acid levels (renal function and urate transport)Metabolomic signatures of renal transporter function/inhibitionDrug/metabolite ratios in urine/blood as surrogate markers for transporter activity

Beyond the preview

Go deeper on Renal transporter.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Renal transporter.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call